Drugs / Citrus Flavone Tablets
Citrus Flavone Tablets
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT07176182 Comparator | Mar 2026 → Mar 2031 expected | rectal cancer | Sixth Affiliated Hospital, Sun Yat-sen University | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Citrus Flavone Tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07176182 ↗ |
| Known as | Aimailang | “citrus flavonoid tablets (Aimailang)” NCT07176182 ↗ |
| Known as | Alvenor | “Citrus flavonoid tablets (Alvenor)” NCT07176182 ↗ |
| Route | Oral | “500 mg orally three times daily” NCT07176182 ↗ |